Roche, Shire court fight underscores high stakes in hemophilia

Jul 10, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

ZURICH (Reuters) – Roche’s bid to muscle in on Shire’s share of the $11 billion hemophilia drug market took a new, contentious turn this weekend when the British drugmaker won a court injunction against how the Swiss drugmaker talks about its new medicine.